课题基金 / 基金详情

Leadership, Planning and Evaluation

Leadership, Planning and Evaluation
领导、规划和评估
批准号:
10171802
负责人:
TYLER E. JACKS
金额:
$12.35万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-06-01 至 2025-04-30

项目摘要

项目成果

TYLER E. JACKS的其他基金

相似基金

相关文献

中文摘要
翻译
领导、规划和评估:项目摘要/摘要 高级领导层与内部和外部咨询小组一起推动规划和评价工作 Koch Institute的活动。支持科赫研究所研究和科学界的决定 (KI)研究的内部和外部评估,共享资源,行政和运营结构 KI通过几个过程发生。在内部,高级领导层和KI执行委员会执行 监督和审查。正式的麻省理工学院评估过程包括由KI主任向 麻省理工学院院长,学术访问委员会的半年审查和年度报告,并定期 与负责研究的副总裁会面。由KI科学咨询委员会提供外部审查 (SAB),每年举行一次会议,审查CCSG计划,总体目标和进展情况, 结构和共享资源。 麻省理工学院对科赫研究所的研究、共享资源、管理和运营结构的评估 通过几个过程发生。麻省理工学院正式的内部评估程序包括科赫公司的年度报告, 研究所所长向麻省理工学院校长汇报,并与副校长举行年度报告和预算会议, Research.科赫研究所还接受生物学系访问委员会的审查, 它由麻省理工学院公司任命,由麻省理工学院以外的杰出科学家组成, 工业界的个人。最近一次访问委员会会议于2019年春季举行。这些 评估用于确定麻省理工学院对KI的财政支持和空间分配;两者都有 在上一个资助期内,科赫研究所获得的资助有所增加,这反映了科赫研究所在麻省理工学院内的良好声誉和地位。 科赫研究所有几种额外的规划和评估方法。其中最主要的是 科赫研究所年度务虚会和双周科赫研究所CCSG计划和教师会议。年度 场外务虚会已被证明是科赫研究所成员及其实验室的一个极好的机会, 正式和非正式地互相交流并讨论他们的科学。它们也非常有用, 科赫研究所的领导,以评估计划和成员作为一个整体;近年来,务虚会 也被用作评估潜在科赫研究所成员候选资格的机制。在 此外,科赫研究所成员在学年期间大约每两周举行一次会议, 讨论科学发展,科赫研究所的业务和未来的方向。强有力的机制, 对科赫研究所核心设施进行审查,以确保满足中心成员的科学需求。
英文摘要
Leadership, Planning and Evaluation: Project Summary/Abstract The senior leadership, in conjunction with internal and external advisory groups, drives planning and evaluation activities at the Koch Institute. Decisions to support the research and scientific community of the Koch Institute (KI), internal and external evaluation of the research, shared resources, administration and operating structure of the KI occurs via several processes. Internally, Senior Leadership and the KI Executive Committee perform oversight and review. Formal MIT evaluation processes include an annual report by the KI Director to the President of MIT, bi-annual review by academic visiting committees and an annual report to, and regular meetings with, the Vice President for Research. External review is provided by the KI Scientific Advisory Board (SAB), which meets annually and reviews the CCSG Programs, overall aims and progress, the administrative structure and shared resources. MIT evaluation of the research, shared resources, administration and operating structure of the Koch Institute occurs via several processes. Formal internal MIT evaluation processes include an annual report by the Koch Institute Director to the President of MIT and an annual report and budget meeting with the Vice President for Research. The Koch Institute is also subject to review by the Visiting Committee of the Department of Biology, which is appointed by the MIT Corporation and is made up of prominent scientists from outside of MIT and individuals from industry. The most recent Visiting Committee meeting was held in spring 2019. These evaluations are used in determining financial support and space allocations by MIT to the KI; both have increased over the last grant period, reflecting the strong reputation and status of the Koch Institute within MIT. The Koch Institute has several additional means of planning and evaluation. Principal among these are the Koch Institute Annual Retreat and bi-weekly Koch Institute CCSG Program and Faculty Meetings. The annual off-site retreats have proven to be an excellent opportunity for Koch Institute members and their laboratories to engage with each other and discuss their science, formally and informally. They are also very useful for the Koch Institute leadership to evaluate the Programs and membership as a whole; in recent years, the retreats have also been used as a mechanism to evaluate the candidacy of potential Koch Institute members. In addition, the Koch Institute members meet approximately every two weeks during the academic year to discuss scientific developments, Koch Institute business, and future directions. Strong mechanisms for ongoing review of Koch Institute Core Facilities are in place to ensure scientific needs of the Center members are met.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Studying factors controlling cancer progression and immune recognition in mouse models
Developmental Funds
Development of novel metastatic mouse models that recapitulate the major immune contexts of human colon cancer
Development of novel metastatic mouse models that recapitulate the major immune contexts of human colon cancer
海外基金